Kidney diseases (Basel, Switzerland)
Oct 27, 2021
INTRODUCTION: Understanding heterogeneity in the prognosis of chronic kidney disease (CKD) has implications in management of patients. We aimed to evaluate the comparative risk of end-stage kidney disease (ESKD), cardiovascular (CV) events, and death...
Kidney diseases (Basel, Switzerland)
Nov 6, 2020
BACKGROUND: Related studies have demonstrated a relationship of elevated serum uric levels with a decline in kidney function. However, limited evidence exists in a Southeast Asian community-based population.
Kidney diseases (Basel, Switzerland)
Sep 15, 2020
BACKGROUND: The prevalence of acute kidney injury (AKI) in COVID-19 patients is high, with poor prognosis. Early identification of COVID-19 patients who are at risk for AKI and may develop critical illness and death is of great importance.
Kidney diseases (Basel, Switzerland)
Dec 3, 2019
BACKGROUND: Artificial intelligence (AI) now plays a critical role in almost every area of our daily lives and academic disciplines due to the growth of computing power, advances in methods and techniques, and the explosion of the amount of data; med...
Kidney diseases (Basel, Switzerland)
Oct 18, 2019
BACKGROUND: Metabolic acidosis, which is classified into either high anion gap type (high-AGMA) or non-anion gap type (non-AGMA), is a common complication in chronic kidney disease (CKD), but its development in CKD is obscure.
Kidney diseases (Basel, Switzerland)
Nov 29, 2018
BACKGROUND: Tolvaptan is a promising drug for the prevention of contrast-induced acute kidney injury (CI-AKI) because it induces aquaresis without adversely affecting renal hemodynamics. CI-AKI is a major cause of acute renal failure associated with ...
Kidney diseases (Basel, Switzerland)
Nov 16, 2018
BACKGROUND: A low estimated glomerular filtration rate (eGFR) and an increased urinary albumin-to-creatinine ratio (ACR) are well-recognised prognostic markers of cardiovascular (CV) risk, but their individual and combined relationship with CV diseas...
Kidney diseases (Basel, Switzerland)
Nov 7, 2018
BACKGROUND: Fluid volume and blood pressure (BP) management are crucial endpoints for end-stage kidney disease patients. BP control in clinical practice mainly relies on reducing extracellular fluid volume overload by diminishing targeted postdialysi...
Kidney diseases (Basel, Switzerland)
Oct 25, 2018
BACKGROUND: Modern clinical environments are laden with technology devices continuously gathering physiological data from patients. This is especially true in critical care environments, where life-saving decisions may have to be made on the basis of...
Kidney diseases (Basel, Switzerland)
Oct 12, 2018
Reinforcement learning has achieved tremendous success in recent years, notably in complex games such as Atari, Go, and chess. In large part, this success has been made possible by powerful function approximation methods in the form of deep neural ne...